Table 2.
Gender |
Substance Use Disorders |
||||
Time Period |
Female |
Male |
No |
Yes |
|
ΔMean (95% CI) | ΔMean (95% CI) | ΔMean (95% CI) | ΔMean (95% CI) | ||
1: Baseline Jan 2006–Jan 2008 | −3.7 (−5.6 to − 1.9) | −5.3 (−9.4 to − 1.3) | −3.8 (−5.8 to − 1.8) | −8.8 (−17.0 to − 0.6) | |
P* | 0.479 | 0.263 | |||
2: Dose reduction Jan 2008–Oct 2010 | −5.9 (−7.0 to − 4.8) | −8.8 (−10.8 to − 6.9) | −6.5 (−7.6 to − 5.5) | −10.7 (−14.9 to − 6.5) | |
P* | 0.010 | 0.064 | |||
3: Risk mitigation Oct 2010–Sep 2014 | −1.3 (−2.1 to − 0.6) | −1.5 (−2.7 to − 0.3) | −1.5 (−2.1 to − 0.8) | −0.8 (−3.4 to 1.9) | |
P* | 0.851 | 0.635 | |||
Mental Disorders |
Any Sedative Use |
||||
Time period |
No |
Yes |
No |
Yes |
|
ΔMean (95% CI) | ΔMean (95% CI) | ΔMean (95% CI) | ΔMean (95% CI) | ||
1: Baseline Jan 2006–Jan 2008 | −3.7 (−6.5 to − 1.0) | −5.0 (−7.7 to − 2.3) | −3.8 (−6.0 to − 1.6) | −5.3 (−8.6 to − 2.0) | |
P* | 0.539 | 0.456 | |||
2: Dose reduction Jan 2008–Oct 2010 | −5.2 (−6.6 to − 3.8) | −8.2 (−9.7 to − 6.7) | −5.8 (−7.0 to − 4.6) | −9.2 (−11.1 to − 7.2) | |
P* | 0.005 | 0.004 | |||
3: Risk mitigation Oct 2010–Sep 2014 | −1.1 (−2.2 to 0.0) | −1.5 (−2.4 to − 0.7) | −1.3 (−2.1 to − 0.6) | −1.6 (−2.7 to − 0.5) | |
P* | 0.605 | 0.716 |
CI = confidence interval.
Each P value is based on a 1-degree-of-freedom Wald chi-square test for the difference in rates of change between the two groups within the given time period. Boldface indicates statistical significance (P < 0.05).